Overall verdict
Neutral
5.5/10
1-year performance
+3.55%
Score breakdown
Up 3.5% over 1 year, 62% of the 52-week range.
Strongest: Profitability 9.2/10. Weakest: Growth 5.0/10.
16 analysts, target +0.1% vs the price.
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related products under the Huggies, Pull-Ups, Goodnites, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, Wypall, and other brand names.
Its International Personal Care segment provides baby and child care, adult care and feminine care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Kotex, Goodfeel, Intimus, Depend, and other brand names. The company sells its household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce.
It also sells its professional use products through distributors directly to manufacturing, lodging, office building, food service, and high-volume public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Sector
Consumer Staples
Industry
Household Products
Primary listing
Nasdaq
United States
CEO
Michael Hsu
Founded
1872
Employees
36 000
Revenue / employee
456 861 USD
Next earnings
January 26, 2027 (estimated)
Institutional holders
- FMR LLC3.20%
- GEODE CAPITAL MANAGEMENT, LLC1.86%
- Bank of New York Mellon Corp0.35%
- Rest of the register94.59%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
116.82 USD
52-week low
92.42 USD
1-year performance
3.55%
Rising
Year-to-date performance
6.21%
Rising
Drawdown
-8.00%
Mild pullback
Position in the 52-week range
62% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned less, while shaking 1.2 times harder.
$10,000 placed at the end of December 2000 are worth today
| Kimberly-Clark | $38,165 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves 1.2 times as much as the world ETF.
- Worst fall:-34Â % between March 2025 and April 2026. $10,000 placed at the top fell to $6,594. The world ETF, at worst: -53Â %. The share has not returned to its high yet.
Kimberly-Clark earned less than the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- Kimberly-Clark: $38,165
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Range: 90.00 USD - 162.00 USD (2 methods agree)
The price implies growth of 11.91% per year; the company grows at -2.45%.
Gross margin 36.5%, net margin 10.5%, ROIC 21.0%, ROE 81.9%.
Net margin
10.55%
High
Sector 8.27%|S&P 13.40%
Gross margin
36.48%
Fair
Return on equity (ROE)
81.94%
Exceptional
Sector 12.31%|S&P 17.06%
Return on invested capital (ROIC)
21.04%
Exceptional
Free cash flow margin (FCF)
11.73%
High
Profit-to-cash conversion (FCF conversion)
1.11x
High
Margin stability
2.0 pts
Very steady
Revenue to net income
Growth
5.0/10Revenue down 0.4% over 1 year, -3.0% a year over 5, EPS -2.5% a year over 5.
Revenue (trailing 12 months)
16.6Md USD
Revenue growth (1y)
-0.39%
Declining
Revenue growth (3y)
-18.48%
Declining
EPS growth (1y)
301.31%
Hyper-growth
EPS CAGR (5y)
-2.45%
Declining
EPS revisions (3 months)
-8.45%
Sharply revised down
Valuation
5.9/10P/E 10.9x, forward P/E 41.3x, EV/EBITDA 22.3x, PEG 0.16. The multiple sits in the 33th percentile of its own 5-year history.
P/E (TTM)
10.9x
Cheap
Sector 19.8x|S&P 23.6x
Forward P/E
41.3x
Fair
EV / EBITDA
22.3x
Very expensive
Sector 10.3x|S&P 15.5x
PEG
0.16
Growth unpriced
Sector 2.28|S&P 0.91
Fair value (reverse DCF)
122.76 USD
Undervalued
P/E vs its own 5-year history
among the 33% lowest valuations
Cheaper than usual
Market cap
65.9Md USD
Financial strength
6.0/10Cash covers 28.9% of the debt, net debt/EBITDA 2.1x.
Net debt / EBITDA
2.1x
Tight
Gearing (net debt / equity)
149.13%
Stretched
Cash
1.9Md USD
Cash / market cap
2.84%
Stretched
Cash / total debt
28.87%
Tight
Interest coverage
11.0x
Very solid
Net debt
4.6Md USD
Equity
3.1Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 110.76 USD
- MM20108.00
- MM50102.69
- MM200103.28
- RSI 1458.7
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.77%
200-day average slope, 3 months
+0.07%
50-day average slope, 1 month
-0.81%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
2.38 % per day
Volatility change
+44.94%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 2.60 (1) | 6.82 (9) | 19 347 (6) | 3 940 (6) | 2 260 (3) |
| 2027 | 6.59 (4) | 7.12 (10) | 32 816 (8) | 7 396 (5) | 4 296 (4) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 11, 2026.
Same sub-industry: 36 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RKT | 6.5 | 6.6 | 47.5Md USD | 13.0x | 21.2 % | 0.3 % | 22.4 % | 1.7x | 4.3 % | -4.0 % | ||
| 2 | HEN3 | 6.1 | 6.1 | 36.8Md USD | 16.7x | 9.4 % | -5.1 % | 8.3 % | 0.2x | 6.3 % | 16.3 % | ||
| 3 | PG | 5.8 | 5.7 | 389Md USD | 25.3x | 18.2 % | 4.0 % | 20.7 % | 1.0x | 3.9 % | 14.9 % | ||
| 4 | 8113 | 5.6 | 4.9 | 12.5Md USD | 31.1x | 6.2 % | 5.3 % | 7.8 % | -1.9x | 5.0 % | 15.0 % | ||
| 5 | KMB | 5.5 | 6.5 | 65.9Md USD | 10.9x | 10.5 % | -0.4 % | 21.0 % | 2.1x | 2.9 % | 3.5 % | ||
| 6 | CHD | 5.4 | 5.2 | 26.4Md USD | 34.5x | 12.4 % | 1.0 % | 11.9 % | 1.5x | 4.0 % | 31.7 % | ||
| 7 | CLX | 5.3 | 5.1 | 12.9Md USD | 19.2x | 9.4 % | 33.3 % | 19.2 % | 4.8x | 3.5 % | 1.8 % | ||
| 8 | CL | 5.1 | 4.8 | 77.9Md USD | 38.3x | 9.6 % | 4.6 % | 26.3 % | 1.5x | 4.9 % | 24.4 % | ||
| 9 | ESSITY B | 5.1 | 5.5 | 19.7Md USD | 17.5x | 8.0 % | 4.1 % | 9.3 % | 1.1x | 6.0 % | 8.0 % |
